Jim Simons
SANA icon

Jim Simons’s Sana Biotechnology SANA Stock Holding History

Jim Simons’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.3M Sell
1,231,100
-220,100
-15% -$709K 0.01% 1544
2026
Q1 		$4.18M Sell
1,451,200
-239,916
-14% -$945K 0.01% 1477
2025
Q4 		$6.88M Sell
1,691,116
-301,384
-15% -$1.35M 0.01% 1120
2025
Q3 		$7.07M Buy
1,992,500
+1,788,788
+878% +$6.47M 0.01% 1286
2025
Q2 		$556K Buy
+203,712
New +$420K ﹤0.01% 2782
2025
Q1 		– Sell
-319,818
Closed -$521K – 3785
2024
Q4 		$521K Buy
319,818
+303,318
+1,838% +$904K ﹤0.01% 2824
2024
Q3 		$68.6K Sell
16,500
-33,400
-67% -$175K ﹤0.01% 3313
2024
Q2 		$272K Sell
49,900
-123,000
-71% -$980K ﹤0.01% 2947
2024
Q1 		$1.73M Sell
172,900
-122,200
-41% -$915K ﹤0.01% 2128
2023
Q4 		$1.2M Buy
295,100
+100,231
+51% +$369K ﹤0.01% 2276
2023
Q3 		$754K Buy
+194,869
New +$1.05M ﹤0.01% 2487
2023
Q2 		– Sell
-61,100
Closed -$200K – 4223
2023
Q1 		$200K Sell
61,100
-104,600
-63% -$418K ﹤0.01% 3280
2022
Q4 		$655K Sell
165,700
-652,300
-80% -$3.19M ﹤0.01% 2781
2022
Q3 		$4.91M Buy
818,000
+31,200
+4% +$225K 0.01% 1456
2022
Q2 		$5.06M Sell
786,800
-53,900
-6% -$343K 0.01% 1547
2022
Q1 		$6.94M Buy
840,700
+783,400
+1,367% +$6.33M 0.01% 1368
2021
Q4 		$887K Buy
+57,300
New +$1.1M ﹤0.01% 2739
2021
Q3 		– Sell
-22,200
Closed -$436K – 3793
2021
Q2 		$436K Buy
+22,200
New +$503K ﹤0.01% 3013

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Flagship Pioneering
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marex Group
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Jim Simons's SANA Position: Q2 2026 in Review

Jim Simons reduced its Sana Biotechnology (SANA) stake by 15% in Q2 2026, selling an estimated $709K and leaving 1,231,100 shares worth $4.3M. The position accounts for 0.01% of the portfolio, ranked #1544.

Jim Simons first reported a position in SANA in Q2 2021 and has held it in 18 quarters since. The position peaked at $7.07M in Q3 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Jim Simons held 1,231,100 shares of Sana Biotechnology worth $4.3M as of Q2 2026.
  • Jim Simons sold 220,100 Sana Biotechnology shares in Q2 2026, an estimated $709K.
  • Sana Biotechnology made up 0.01% of Jim Simons's portfolio in Q2 2026, its #1544 holding.
  • Jim Simons first reported a position in Sana Biotechnology in Q2 2021 and has held it in 18 quarters since.
  • Jim Simons's Sana Biotechnology position peaked at $7.07M in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.